inCerebro
inCerebro is focused on developing a next-generation drug discovery technology that leverages a quantum-driven approach.
inCerebro is focused on developing a next-generation drug discovery technology that leverages a quantum-driven approach.
In Cerebro by VigiCell is a startup at the intersection of analytics, biopharma, and pharmaceutical industries, founded in 2019. The company recently secured a significant KRW5.00B Seed Round investment on 06 July 2021. The round was backed by prominent investors including HB Investment, Timefolio Asset Management, UTC 2019 BioVentureFund, and Albatross Investment.
This latest investment demonstrates strong confidence from notable industry players, signifying the potential of In Cerebro by VigiCell in the rapidly evolving biopharma and pharmaceutical sectors. The funding is expected to fuel the company's growth and further develop its innovative approaches towards analytics within these industries. With the support of these reputable investors, In Cerebro by VigiCell is well-positioned to make significant strides in the coming years.| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | KRW5.00B | 4 |
|
06 Jul 2021 |
| Seed Round | Unknown | 1 |
|
01 Jan 2021 |
| Non Equity Assistance | Unknown | 1 | TIPS Program | 01 Oct 2019 |
No recent news or press coverage available for inCerebro.
We care about your data, and we'd love to use cookies make your experience better.
